Furthermore, the expression of IGF2BP1, METTL3 and METTL14 is strongly correlated with E2F1–3 expression (R = 0.4) across 33 TCGA tumor cohorts (Supplementary Figure S6G). The gene discussed is METTL3; the disease is neoplasm.